Semanteon Capital Management, LP Evolus, Inc. Transaction History
Semanteon Capital Management, LP
- $157 Billion
- Q1 2024
A detailed history of Semanteon Capital Management, LP transactions in Evolus, Inc. stock. As of the latest transaction made, Semanteon Capital Management, LP holds 77,613 shares of EOLS stock, worth $861,504. This represents 0.69% of its overall portfolio holdings.
Number of Shares
77,613
Previous 44,786
73.3%
Holding current value
$861,504
Previous $472 Million
130.4%
% of portfolio
0.69%
Previous 0.32%
Shares
2 transactions
Others Institutions Holding EOLS
# of Institutions
173Shares Held
47MCall Options Held
720KPut Options Held
532K-
Perceptive Advisors LLC New York, NY5.75MShares$63.9 Million1.69% of portfolio
-
Tang Capital Management LLC San Diego, CA4.15MShares$46 Million7.07% of portfolio
-
Black Rock Inc. New York, NY3.26MShares$36.2 Million0.0% of portfolio
-
Morgan Stanley New York, NY3.04MShares$33.8 Million0.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT2.91MShares$32.3 Million2.62% of portfolio
About Evolus, Inc.
- Ticker EOLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 56,094,800
- Market Cap $623M
- Description
- Evolus, Inc., a performance beauty company, provides medical aesthetic products for physicians and their patients in the United States. It offers Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation for the temporary improvement in the appearance of moderate to severe glabellar lines in adults. The company was incorp...